Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing ... - FOXBusiness

21 November 2008, 9:41 am

Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing ...FOXBusiness - 5 hours agoLow platelet counts leave adult ITP patients open to sudden serious bleeding events, making it impossible to arrest blood flow. ...Amgen says CHMP recommends marketing approval for Nplate in ... RTT NewsNplate(TM) (Romiplostim) Receives Positive Opinion for Marketing ... SunHerald.comall 24 news articles... Read More »

More Topics from "Articles"

• BioMarin Announces the Planned Retirement of Dr. Emil Kakkis ... - MarketWatch
• In this economy, every day should be Thanksgiving for PGA Tour players - Examiner.com
• Tagliavini to lead Georgia inquiry - Swissinfo
• SFL - Invitation to Presentation of 3Q 2008 Results - CNNMoney.com
• Chicago bid uses newspaper wraparound promotion - International Herald Tribune
• Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test ... - MarketWatch
• Museum and gallery events - Philadelphia Inquirer
• Zevtera(TM) (ceftobiprole medocaril), the novel anti-MRSA broad ... - FOXBusiness
• Prestigious European Coin Auction Looks to US Experts for Success - MarketWatch